Posted by Clinical Lab Products | Jul 27, 2009 | Miscellaneous |
Quest Diagnostics Inc announces that the FDA has granted an emergency use authorization to the company’s Focus Diagnostics business for its test for detecting the 2009 H1N1 influenza virus (the “pandemic flu virus”), a strain of influenza A virus initially referred to as the swine flu virus.
Read MorePosted by Clinical Lab Products | Jul 23, 2009 | Sexually Transmitted Diseases |
Research presented today at the American Association for Clinical Chemistry annual meeting shows that an assay developed by Abbott for simultaneous detection of both HIV antigens and antibodies reduced the detection window by zero to nine days in this study compared to HIV antibody-only assays. Earlier detection was shown on four of the five panels tested.
Read MorePosted by Clinical Lab Products | Jun 26, 2009 | Miscellaneous |
Chembio Diagnostic Systems Inc has been awarded a small Business Innovative Research (SBIR) Phase II grant to fully develop, validate, and commercialize a rapid diagnostic test for leptospirosis for general use worldwide.
Read MorePosted by Clinical Lab Products | Jun 24, 2009 | Cancer, Miscellaneous |
Laboratory Corp of America Holdings (LabCorp) and Monogram Biosciences Inc today announced that they have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Monogram in a cash tender offer.
Read MorePosted by Clinical Lab Products | Jun 16, 2009 | Cancer, Miscellaneous |
The University of California, San Francisco, has partnered with Abbott to launch a first-of-its kind, non-profit viral diagnostics center near the UCSF Mission Bay campus to help identify unknown viruses from around the world.
Read More